GlassScriptPhysician profile
Melanie Davis
NPI 1972893139
$2,811.85
in general payments reported to CMS, 2019-2025
37 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $286 · 2022: $534 · 2023: $890 · 2024: $785 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $701.77 | 2021-2025 | |
| Novo Nordisk INC | $455.06 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $210.08 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $178.10 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| E.R. Squibb & Sons, L.L.C. | $115.24 | 2022-2024 | Eliquis, Camzyos |
| Pfizer INC. | $104.02 | 2023-2025 | |
| Biohaven Pharmaceuticals, INC. | $80.02 | 2021 | |
| Merck Sharp & Dohme LLC | $75.05 | 2022-2025 | Verquvo, Belsomra, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $71.20 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $64.16 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $57.42 | 2021-2024 | Farxiga, Breztri |
| Inogen, INC. | $56.64 | 2022-2024 | Inogen At Home Stationary Concentrator |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.76 | 2022-2024 | Synjardy, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $49.49 | 2021 | |
| Paratek Pharmaceuticals, INC. | $38.59 | 2022-2023 | Nuzyra |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.